Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer effective February 15, 2025.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...

MidAmerica Cancer Care (MACC), a trusted name in Kansas City and western Missouri cancer care, is proud to announce it has ...

An editor in his early 40s thought the tiny numb spot on his nose was innocuous. A year and six doctors later, he learned it ...

Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.

Bengaluru: In a remarkable achievement, the state-run Kidwai Memorial Institute of Oncology (KMIO), a premier cancer ...

In a report released today, Roger Song from Jefferies maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target of ...

Co., Inc. (NYSE:MRK), a global healthcare leader, faces a complex landscape of opportunities and challenges as it navigates the competitive biopharmaceutical industry. This comprehensive analysis ...

Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...